In the phase 3 SUSTAIN clinical trial program, involving over 8,000 patients with type 2 diabetes, once-weekly semaglutide at 0.5 mg or 1 mg doses achieved mean HbA1c reductions from baseline of 1.2% to 1.8% after 30 to 56 weeks, demonstrating excellent glycemic control, outperforming comparators like sitagliptin, exenatide, and insulin glargine
Similar improvements were observed across all other questionnaire items
Semaglutide , employed for managing obesity and type 2 diabetes, has raised concerns about potential vision loss
The tennis legend sparked backlash last summer when she revealed that she had shed a staggering 31 pounds by using weight loss drug Zepbound, a GLP-1 medication
For instance, the active exclusion of Ca 2+ from the cytosol is impaired, 43 and the resulting increase in cytosolic Ca 2+ induces its uptake by mitochondria, leading to mitochondrial dysfunction and the opening of the mitochondrial permeability transition pore (MPTP)as a cause of cell death
